Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML

NCT01191801 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

711

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: vosaroxin + cytarabine
DRUG: placebo + cytarabine

Sponsor

Sunesis Pharmaceuticals